HERON THERAPEUTICS, INC. /DE/
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $154.9 | $144.3 | $127.0 | $107.7 | $86.3 |
| Operating income | -$2.5 | -$11.5 | -$110.6 | -$174.7 | -$217.8 |
| Net income | -$20.2 | -$13.6 | -$110.6 | -$182.0 | -$220.7 |
| Cash Flow Statement | |||||
| Free cash flow | -$27.9 | -$24.2 | -$60.3 | -$148.7 | -$206.4 |
Shares outstanding 189.9M · Free float 75.7%
Annual filing data through FY ended December 31, 2025; float as of September 21, 2026.